What is Muses Labs?
Muses Labs operates at the vanguard of cognitive health, utilizing a sophisticated clinical precision medicine platform to address the complexities of Alzheimer's disease and age-related cognitive decline. The company integrates three decades of scientific research with advanced data analytics to synthesize individual patient medical and behavioral profiles. Central to its operational model is the MEND Protocol, or Metabolic Enhancement for NeuroDegeneration, which provides a structured, technology-enabled framework for identifying the root causes of memory loss. By offering personalized treatment plans and comprehensive adherence support for caregivers, Muses Labs is effectively bridging the gap between clinical research and actionable patient outcomes in the neurology sector.
How much funding has Muses Labs raised?
Muses Labs has raised a total of $2.8M across 2 funding rounds:
Private Equity
$785K
Private Equity
$2.1M
Private Equity (2014): $785K, investors not publicly disclosed
Private Equity (2017): $2.1M, investors not publicly disclosed
Key Investors in Muses Labs
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Muses Labs?
With this major strategic investment, Muses Labs is poised to accelerate the scaling of its MEND Protocol and expand its clinical footprint. The company's trajectory suggests a shift toward broader market penetration, likely focusing on enhancing its data collection capabilities and refining its algorithmic approach to personalized neuro-care. As the firm moves beyond its initial development phase, the focus will likely shift toward establishing strategic partnerships with healthcare providers and insurance entities to integrate its protocol into standard clinical workflows. This capital infusion provides the necessary runway to solidify its market position and continue its mission of transforming the management of neurodegenerative diseases through data-driven, individualized interventions.
See full Muses Labs company page
